PRV.L

Porvair Plc
Porvair PLC - AGM Trading Update & Board Update
16th April 2024, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 6903K
Porvair PLC
16 April 2024
 

A picture containing text, clipart Description automatically generated

 

 

 

For immediate release                                                                                                                   16 April 2024

Porvair plc ("Porvair" or the "Group")

 

AGM Trading Update

Board Update

Porvair plc, the specialist filtration, laboratory and environmental technology group, will make the following trading statement at its Annual General Meeting later today at 11:00 a.m.

At the time of the results statement in early February the Board noted its optimism for 2024 and beyond, and this has not changed. Opportunities afforded by recent acquisitions; strong order books in aerospace and petrochemical; and new product introductions at Seal Analytical are all developing as planned. De-stocking in laboratory markets is easing and lead times are returning to more normal levels. Industrial consumable order patterns, while still weaker than the prior year, are now also steadier, with several large orders, including one for gasification spares, due to ship at the end of the year and into 2025. As outlined in February, the Board expects a quieter first half of 2024 to be followed by a stronger second half, in line with market expectations.

With the Group trading well, Ben Stocks has indicated his intention to retire in early 2025 once a successor has been appointed and settled into the role. The Nominations Committee has started a search both internally and externally and will report progress as appropriate.

The Group will announce its interim results for the six months ending 31 May 2024 on Monday 1 July 2024.

 

For further information, please contact:

 

Porvair plc


Ben Stocks, Group Chief Executive

01553 765 500

James Mills, Group Finance Director




Buchanan Communications

020 7466 5000

Charles Ryland / Stephanie Whitmore


 

Notes to Editors

Porvair is a group of specialist filtration, laboratory and environmental technology businesses.  Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFIRSDIELIS]]>
TwitterFacebookLinkedIn